The short version
Only one company currently supplies this market — there is no backup if it stumbles.
Market view
etripamil · Oil
1 marketed package NDCs · 1 active manufacturer
Most dispensed: 70 mg/.2mL · Spray · #2 containers/carton / 2 vial, single-dose in 1 container / .2 ml in 1 vial, single-dose
What changed in the last 90 days
Every detected change for etripamil, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- CardamystAug 19, 2026Price downNADAC $790.41667 → $790.273 per unit (-0.02%)
Common questions
- Is Etripamil in shortage right now?
- No. FDA does not currently list Etripamil in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Etripamil?
- 3 companies have marketed Etripamil in the last 30 days, according to the FDA NDC Directory. That is a thin market — if one stops making it, supply is at risk quickly. Every manufacturer and package is listed on this page.
- What does Etripamil cost?
- The typical pharmacy pays about $790.27 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.